On Friday, Relmada Therapeutics Inc (NASDAQ: RLMD) was 6.00% up from the session before settling in for the closing price of $4.0. A 52-week range for RLMD has been $0.24 – $5.12.
A company in the Healthcare sector has jumped its sales by 0.68% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 68.68%. With a float of $50.90 million, this company’s outstanding shares have now reached $73.33 million.
Relmada Therapeutics Inc (RLMD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Relmada Therapeutics Inc stocks. The insider ownership of Relmada Therapeutics Inc is 30.59%, while institutional ownership is 14.57%. The most recent insider transaction that took place on Nov 05 ’25, was worth 1,100,000. In this transaction Chief Financial Officer of this company bought 500,000 shares at a rate of $2.20, taking the stock ownership to the 788,335 shares. Before that another transaction happened on Nov 05 ’25, when Company’s CAO and COO bought 136,000 for $2.20, making the entire transaction worth $299,200. This insider now owns 403,931 shares in total.
Relmada Therapeutics Inc (RLMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 68.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.22% during the next five years compared to 0.68% growth over the previous five years of trading.
Relmada Therapeutics Inc (NASDAQ: RLMD) Trading Performance Indicators
You can see what Relmada Therapeutics Inc (RLMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of Relmada Therapeutics Inc (RLMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.07 million. That was inferior than the volume of 1.18 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.51%.
During the past 100 days, Relmada Therapeutics Inc’s (RLMD) raw stochastic average was set at 80.74%, which indicates a significant increase from 38.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was higher than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.92, while its 200-day Moving Average is $1.21. However, in the short run, Relmada Therapeutics Inc’s stock first resistance to watch stands at $4.37. Second resistance stands at $4.50. The third major resistance level sits at $4.69. If the price goes on to break the first support level at $4.05, it is likely to go to the next support level at $3.86. The third support level lies at $3.73 if the price breaches the second support level.
Relmada Therapeutics Inc (NASDAQ: RLMD) Key Stats
There are 73,334K outstanding shares of the company, which has a market capitalization of 310.93 million. As of now, sales total 0 K while income totals -79,980 K. Its latest quarter income was 0 K while its last quarter net income were -10,090 K.
